Palvella Therapeutics, Inc. (PVLA)
NASDAQ: PVLA · Real-Time Price · USD
149.97
-0.36 (-0.24%)
Aug 28, 2026, 4:00 PM EDT - Market closed
Palvella Therapeutics Market Cap
Palvella Therapeutics has a market cap or net worth of $2.16 billion as of August 28, 2026. Its market cap has increased by 246.11% in one year.
Market Cap
2.16B
Enterprise Value
1.93B
1-Year Change
246.11%
Ranking
Category
Stock Price
$149.97
ChartMarket Cap Chart
Since December 16, 2024, Palvella Therapeutics's market cap has increased from $143.97M to $2.16B, an increase of 1,400.89%. That is a compound annual growth rate of 392.64%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 28, 2026 | 2.16B | 74.41% |
| Dec 31, 2025 | 1.24B | 820.07% |
| Dec 31, 2024 | 134.66M | -6.47% |
| Dec 16, 2024 | 143.97M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Harmony Biosciences Holdings | 2.28B |
| Ocular Therapeutix | 2.28B |
| Mineralys Therapeutics | 2.26B |
| Sarepta Therapeutics | 2.20B |
| Aurinia Pharmaceuticals | 2.17B |
| Nanobiotix | 2.13B |
| UroGen Pharma | 2.13B |
| Kailera Therapeutics | 2.10B |